Case Study: Ibtisaam Basier's Journey with Juvenile Chronic Rheumatoid Arthritis
Case Background
Ibtisaam is 29and contracted Rheumatoid Arthritis (RA) at 9 and required an electric wheelchair from age 15. At 16 Ibtisaam was on a biologic medication trial for her RA which was not successful in her case.
Before starting sessions she experienced pain and stiffness throughout her body with low mobility in her shoulders and hands, and required surgery on the ligaments in her hand.
The following analysis was done using ChatGPT.
Analysis
Ibtisaam Basier’s journey with Juvenile Chronic Rheumatoid Arthritis (RA) and her response to KineDek AI-CRT sessions
demonstrates the potential for non-invasive intervention to restore function,
reduce inflammation, and alleviate symptoms in severe cases of RA. Her case
reveals insights into the effectiveness of exercising on the KineDek for managing
chronic, autoimmune conditions.
1. Initial
Condition and Long-Term RA Impact
Ibtisaam, diagnosed with RA at the age of 9,
had experienced nearly two decades of the disease’s debilitating effects by the
time she began KineDek sessions at 29. Her RA had severely impacted her
mobility, leading to the use of an electric wheelchair at 15. The disease
affected her shoulders, hands, and overall body, causing pain, stiffness, and
weakness. Despite undergoing a biologic medication trial at 16, it proved
unsuccessful, and Ibtisaam continued to experience progressive deterioration of
functionality, with surgery planned for her hand ligaments due to inflammation
and damage.
2. Pain
Reduction and Restoration of Functionality
Following her first KineDek session on February 26, 2024, Ibtisaam experienced significant pain relief across her body, particularly in her hands, arms, and shoulders. This rapid improvement is a strong indication of AI-CRTs capacity to reduce inflammation and enhance joint mobility in a short period of time. The normalization of functionality in her hands, arms, and shoulders allowed her to regain dexterity in daily tasks like typing on her phone and computer, which had been severely restricted before.
3. Postponed
Hand Surgery Due to Inflammation Reduction
One of the most significant outcomes of
Ibtisaam’s early sessions was the postponement of her scheduled hand surgery.
During her consultation, just two days after her first session, doctors
observed that the inflammation in her hand had subsided to the point that
surgery was no longer deemed necessary. This is a testament to Ai-CRTs potential in mitigating the inflammatory processes associated with RA, offering
a non-surgical alternative for managing symptoms.
4. Strength
and Stamina Gains
Over the course of the sessions, Ibtisaam
reported substantial improvements in strength and stamina. Given her history of
significant muscle weakness, particularly in her hands, the gradual strength
restoration is remarkable. AI[CRT’s adjustable resistance settings, including
the lowest setting (0.5kg with minimized eccentric contraction), allowed
Ibtisaam to participate in the sessions without overexertion, particularly in
exercises involving her weakened hands. The careful adjustment of resistance based
on her abilities helped facilitate muscle engagement without causing further
strain, likely contributing to her recovery and functionality improvements.
5. Improved
Sleep Quality and Balance
Ibtisaam also reported improved sleep quality,
which is an important factor in managing chronic conditions like RA. Better
sleep likely contributed to her overall recovery, as restful sleep is critical
for reducing inflammation and promoting physical restoration. Additionally, she
noted improvements in balance and coordination, which suggests that AI-CRT may
have helped strengthen the muscles and neural pathways necessary for
maintaining postural stability. This improvement in balance is particularly important
for someone who had been in an electric wheelchair since adolescence.
6. Sustained
Stability After Sessions
By April 22, 2024, Ibtisaam reported being
stable and symptom-free, with continued improvements in strength and balance
even after her last session on April 11, 2024. This extended period of
stability, nearly seven weeks without KineDek sessions, suggests that the
benefits of the exercise were lasting. Her ability to continue making
improvements independently without the need for medication or surgery
highlights AI-CRT’s potential for promoting long-term symptom management.
7. Relapse
of Symptoms After Seven Weeks
On May 28, 2024, almost seven weeks after her last session, Ibtisaam reported that her body was starting to feel heavy again. This gradual return of symptoms aligns with the chronic nature of RA, which typically requires ongoing management to prevent flare-ups. The heaviness she described may indicate a resurgence of inflammation or muscle fatigue, suggesting that regular KineDek sessions may be necessary for maintaining symptom relief and functional improvements in the long term.
Conclusion
Ibtisaam Basier’s case illustrates the
profound impact KineDek AI-CRT can have on individuals suffering from severe,
long-term RA. The exercise provided immediate and significant pain relief,
halted the need for surgery, and allowed for a remarkable restoration of
mobility and strength. The fact that she was able to sustain these benefits for
nearly two months after her last session underscores the lasting effects of the
intervention. However, the return of symptoms after seven weeks suggests that
KineDek sessions may need to be integrated into a long-term management plan to ensure
continued improvement and prevent relapse. This case offers compelling evidence
for the use of KineDek AI-CRT in aiding mobility chronic inflammatory conditions like RA,
with the potential to offer a non-invasive, drug-free intervention to compliment traditional therapies.
For more on Ibtisaam’s story go to 'My life has been brought to a complete standstill' - Cape Town woman needs new wheelchair
Disclaimer: The above has been feedback from the personal experiences of an individual who have used the KineDek. These accounts are individual to each person and are not to be taken as a guarantee that others will experience the same outcomes. The KineDek is not presented as a cure for any condition. Rather, it serves as an enabler for exercise, particularly for those who may otherwise find traditional forms of exercise challenging or painful. Through its AI-enabled Compensating Resistance Technology (AI-CRT), the KineDek allows individuals to engage in physical activity without perceived pain, strain, or subsequent inflammation. Consequently, users can enjoy the well-documented benefits of "Exercise as Medicine." If you have a serious medical condition, always consult with a healthcare professional before starting any new exercise regimen.
